Investor mix
4 investors on record; lead investors include Yorkville Advisors; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |
Developer of vaccines to treat pandemic and seasonal influenza
4 investors on record; lead investors include Yorkville Advisors; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |